THE CHACALTAYA HIGH ALTITUDE LABORATORY

1 Barcroft J CA Binger Observations upon the effect of high altitude on the physiological processes of the human body Bock AV. carried out in the Peruvian A ndes, chiefly at Cerro de Pasco. Philos Trans R Soc London Ser B 1923; 211:351—480.

2Hackett PH,Yarnell PR, Hill R High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA 1998; 280:1920—5.

3 Schoene RB PH Hackett Henderson WR High-altitude pulmonary edema. Characteristics of lung lavage fluid. JAMA 1986; 256:63—9.

4 Hackett PH The incidence Rennie D. , importance, and prophylaxis of acute mountain sickness. Lancet 1976; 2: 1149—55.

5 Vargas M J Osorio Jimenez D Acute mountain sickness at 3500 and 4250 m. A study of symptom, incidence and severity. Rev Med Chil 2001; 129: 166—72.

6 Hackett PH Roach RC. High-altitude illness. N Engl J Med 2001; 345: 107—14.

7 Barry PW NP Mason Riordan M Cough frequency and cough-receptor sensitivity are increased in man at altitude. Clin Sci (Lond) 1997; 93: 181—6.

8The 1998 Chacaltaya Expedition. Expedition Report 1998. The Royal Danish Academy of Sciences and Letters, and Academia Nacional de Ciencias de Bolivia. Available on request from Dr B Saltin, The Copenhagen Muscle Research Centre, Rigshospitalet (University Hospital), Copenhagen, Denmark.

9 Bartsch P M Maggiorini Ritter M Prevention of high-altitude pulmonary edema by nifedipine [see comments]. N Engl J Med 1991; 325: 1284—9.

10 Keller HR M Maggiorini Bartsch P Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial [see comments]. BMJ 1995; 310: 1232—5.